Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.160
-0.040 (-3.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Atossa Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Atossa Therapeutics stock have an average target of 6.13, with a low estimate of 6.00 and a high estimate of 6.25. The average target predicts an increase of 428.45% from the current stock price of 1.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ATOS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6 → $6.25 | Strong Buy | Maintains | $6 → $6.25 | +438.79% | Jun 6, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $6 | Strong Buy | Maintains | $4 → $6 | +417.24% | May 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +244.83% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.24
from -0.24
EPS Next Year
-0.28
from -0.24
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 171.6M | 275.2M | 708.8M |
Avg | n/a | n/a | 55.6M | 123.7M | 347.9M |
Low | n/a | n/a | n/a | n/a | 13.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 395.5% | 473.0% |
Avg | - | - | - | 122.7% | 181.2% |
Low | - | - | - | - | -89.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.23 | -0.26 | -0.23 | 1.31 | 2.95 |
Avg | -0.24 | -0.28 | -0.25 | 0.41 | 1.46 |
Low | -0.24 | -0.30 | -0.26 | -0.22 | -0.18 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 611.2% |
Avg | - | - | - | - | 251.6% |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.